Manila: French pharmaceutical giant Sanofi urged the Philippines to lift the suspension of its anti-dengue vaccine, insisting it was safe, but the government accused the firm of “dishonesty”.
Sales of Dengvaxia and a landmark public immunisation programme using the vaccine were suspended by the Philippines this month after Sanofi warned it could lead to “severe” symptoms for people who had not previously been infected with dengue.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!